- Home
- NTZ vs TENX Comparison
NTZ vs TENX Comparison
Compare NTZ & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTZ
- TENX
- Stock Information
- Founded
- NTZ 1959
- TENX 1967
- Country
- NTZ Italy
- TENX United States
- Employees
- NTZ N/A
- TENX N/A
- Industry
- NTZ Home Furnishings
- TENX Biotechnology: Pharmaceutical Preparations
- Sector
- NTZ Consumer Discretionary
- TENX Health Care
- Exchange
- NTZ Nasdaq
- TENX Nasdaq
- Market Cap
- NTZ 29.4M
- TENX 31.9M
- IPO Year
- NTZ 1993
- TENX N/A
- Fundamental
- Price
- NTZ $2.67
- TENX $7.22
- Analyst Decision
- NTZ
- TENX Strong Buy
- Analyst Count
- NTZ 0
- TENX 2
- Target Price
- NTZ N/A
- TENX $17.00
- AVG Volume (30 Days)
- NTZ 2.7K
- TENX 65.9K
- Earning Date
- NTZ 04-13-2023
- TENX 11-12-2025
- Dividend Yield
- NTZ N/A
- TENX N/A
- EPS Growth
- NTZ N/A
- TENX N/A
- EPS
- NTZ N/A
- TENX N/A
- Revenue
- NTZ $337,653,480.00
- TENX N/A
- Revenue This Year
- NTZ N/A
- TENX N/A
- Revenue Next Year
- NTZ N/A
- TENX N/A
- P/E Ratio
- NTZ N/A
- TENX N/A
- Revenue Growth
- NTZ N/A
- TENX N/A
- 52 Week Low
- NTZ $2.15
- TENX $4.63
- 52 Week High
- NTZ $6.27
- TENX $8.24
- Technical
- Relative Strength Index (RSI)
- NTZ 37.97
- TENX 55.59
- Support Level
- NTZ $2.61
- TENX $6.60
- Resistance Level
- NTZ $3.15
- TENX $7.19
- Average True Range (ATR)
- NTZ 0.08
- TENX 0.38
- MACD
- NTZ -0.03
- TENX -0.02
- Stochastic Oscillator
- NTZ 9.38
- TENX 66.39
About NTZ Natuzzi S.p.A.
Natuzzi SpA is an Italian firm that designs, manufactures, and sells contemporary and traditional leather and fabric-upholstered furniture. Its product portfolio includes sofas, loveseats, armchairs, sectional furniture, motion furniture and sofa beds, living room furnishings, and accessories. The company markets its products under several brands such as Natuzzi Italia, Private label, and Natuzzi Editions. Geographically, it derives a majority of its revenue from the United States of America and also has an international presence in Italy, Spain, the UK, China, and Other countries.
About TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.